Nanoview Biosciences

About:

Nanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine.

Website: http://nanoviewbio.com

Twitter/X: nanoviewbio

Top Investors: National Science Foundation, MassVentures, Sands Capital Ventures, Northpond Ventures, PBM Capital Group

Description:

nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.

Total Funding Amount:

$25.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)nanoviewbio.com

Founders:

David Freedman, George Daaboul

Number of Employees:

11-50

Last Funding Date:

2022-03-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai